Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis. Panichakul T, Intachote P, Wongkajorsilp A, Sripa B, Sirisinha S Anticancer Res26p259-65(2006 Jan-Feb)

28 Jan 2006
0
0

Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis.
Panichakul T, Intachote P, Wongkajorsilp A, Sripa B, Sirisinha S
Anticancer Res26p259-65(2006 Jan-Feb)

Tags

Share this

Related Posts

Khunnawutmanotham, N.; Laongthipparos, C.; Saparpakorn, P.; Chimnoi, N.; Techasakul, S. Synthesis of 3-Aminocoumarin-N-Benzylpyridinium Conjugates with Nanomolar Inhibitory Activity against Acetylcholinesterase. Beilstein J. Org. Chem. 2018, 14, 2545–2552.
28 Dec 2018
0

Khunnawutmanotham, N.; Laongthipparos, C.; Saparpakorn, P.; Chimnoi, N.; Techasakul, S. Synthesis of 3-Aminocoumarin-N-Benzylpyridinium Conjugates with Nanomolar Inhibitory Activity against Acetylcholinesterase. Beilstein J. Org. Chem. 2018, 14, 2545–2552.

Khunnawutmanotham, N.;Laongthipparos, C.;Saparpakorn, P.;Chimnoi, N.;Techasakul, S. Synthesis of 3-Aminocoumarin-N-Benzylpyridinium Conjugates with Nanomolar Inhibitory Activity against Acetylcholinesterase. Beilstein J. Org. Chem.2018, 14, 2545–2552.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More